✦ LIBER ✦

1-phenyl-3-pyrazolidone: An inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets

✍ Scribed by G.J. Blackwell; R.J. Flower

Book ID: 119048776
Publisher: Elsevier Science
Year: 1978
Tongue: English
Weight: 436 KB
Volume: 16
Category: Article
ISSN: 0090-6980
DOI: 10.1016/0090-6980(78)90220-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of inhibitors of cyclo-oxyge

The effects of inhibitors of cyclo-oxygenase, lipoxygenase and nitric oxide synthase pathways on the toxicity of hydroxyurea in adrenalectomized rats

✍ P. Navarra; G. Tringali; P. Preziosi 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 527 KB

An in vitro study of the effect of lipox

An in vitro study of the effect of lipoxygenase and cyclo-oxygenase inhibitors of arachidonic acid on the induction and maintenance of long-term potentiation in the hippocampus

✍ Williams, J.H.; Bliss, T.V.P. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Role of systemic and local administratio

Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats

✍ C. M. Queiroz-Junior; C. M. F. Pacheco; K. L. M. Maltos; M. V. Caliari; I. D. G. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

4-[5-Fluoro-3-[4-(2-methyl-1 H -imidazol

4-[5-Fluoro-3-[4-(2-methyl-1 H -imidazol-1-yl)benzyloxy]phenyl]-3,4,5,6- tetrahydro-2 H -pyran-4-carboxamide, an Orally Active Inhibitor of 5-Lipoxygenase with Improved Pharmacokinetic and Toxicology Characteristics

✍ Mano, Takashi; Okumura, Yoshiyuki; Sakakibara, Minoru; Okumura, Takako; Tamura, 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 97 KB

Evaluation of mannich bases and related

Evaluation of mannich bases and related compounds as inhibitors of mitochondrial function in yeast and inhibition of blood platelet aggregation, blood clotting, and in vitro metabolism of 5-dimethylamino-1-phenyl-1-penten-3-one hydrochloride

✍ J. R. Dimmock; N. W. Hamon; K. W. Hindmarsh; D. G. Mills; L. E. Negrave; G. H. R 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 765 KB

Phase I Study of Rigosertib, an Inhibito

Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer

✍ Ma, W. W.; Messersmith, W. A.; Dy, G. K.; Weekes, C. D.; Whitworth, A.; Ren, C.; 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 440 KB